Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,600,716
  • Shares Outstanding, K 214,786
  • Annual Sales, $ 872,000 K
  • Annual Income, $ -23,550 K
  • 60-Month Beta 1.08
  • Price/Sales 4.97
  • Price/Cash Flow N/A
  • Price/Book 12.57
Trade HIMS with:

Options Overview Details

View History
  • Implied Volatility 78.02% ( -6.50%)
  • Historical Volatility 105.19%
  • IV Percentile 85%
  • IV Rank 50.02%
  • IV High 112.84% on 05/03/24
  • IV Low 43.17% on 09/14/23
  • Put/Call Vol Ratio 0.40
  • Today's Volume 13,102
  • Volume Avg (30-Day) 44,296
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 339,127
  • Open Int (30-Day) 299,467

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.05
  • Number of Estimates 7
  • High Estimate 0.06
  • Low Estimate 0.02
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.80 +12.82%
on 06/27/24
25.74 -17.60%
on 06/18/24
+1.79 (+9.22%)
since 05/31/24
3-Month
11.20 +89.37%
on 05/03/24
25.74 -17.60%
on 06/18/24
+6.22 (+41.49%)
since 04/02/24
52-Week
5.65 +275.40%
on 10/30/23
25.74 -17.60%
on 06/18/24
+11.81 (+125.64%)
since 06/30/23

Most Recent Stories

More News
3 Stocks That Can Double Again in 2024

It wasn't easy to double in 2024, but these three stocks made it happen. They might be able to do it again.

CAVA : 94.59 (-0.71%)
HIMS : 21.21 (-0.98%)
SG : 27.97 (-4.64%)
Is Hims & Hers Stock a Buy After Short Report?

There are valid points in the short report, but it may present a buying opportunity for long-term investors.

UBER : 70.67 (-0.60%)
HIMS : 21.21 (-0.98%)
Hims & Hers Stock Drops 12.8% After Short Report

Is this a warning or a buy sign for Hims & Hers stock?

HIMS : 21.21 (-0.98%)
2 Top Growth Stocks to Buy With $500 Right Now

These top stocks have roaring growth stories to follow.

HIMS : 21.21 (-0.98%)
CAVA : 94.59 (-0.71%)
Why Hims Is a 10x Stock

Disrupting the medical industry has enormous upside.

TGT : 145.39 (-0.24%)
WBA : 11.57 (-0.09%)
HIMS : 21.21 (-0.98%)
Should You Buy Hims & Hers Health Stock Right Now?

The telehealth company is offering innovative products at lower prices.

HIMS : 21.21 (-0.98%)
This Warren Buffett Stock is the Newest GLP-1 Weight-Loss Contender

Amid rising demand for weight management drugs, this Warren Buffett stock is the newest entry.

NVO : 142.98 (-1.68%)
LLY : 906.71 (-0.84%)
COST : 859.36 (+1.62%)
HIMS : 21.21 (-0.98%)
KR : 50.43 (-0.26%)
BRK.A : 610,668.00 (+0.03%)
BRK.B : 407.10 (+0.47%)
XRT : 73.69 (+0.12%)
WMT : 68.07 (+0.87%)
Chart of the Day: Hims & Hers Health - Good Growth in Good Sex

The Chart of the Day belongs to the sex health company Hims & Hers Health (HIMS) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

HIMS : 21.21 (-0.98%)
Hims & Hers Health Stock Soared This Week: Here's Why

The company is still riding momentum from its recent weight loss drug announcement.

HIMS : 21.21 (-0.98%)
A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS : 21.21 (-0.98%)
NVO : 142.98 (-1.68%)
LLY : 906.71 (-0.84%)
XPOF : 16.05 (+6.43%)
WIX : 157.73 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 23.38
2nd Resistance Point 22.68
1st Resistance Point 21.94
Last Price 21.21
1st Support Level 20.50
2nd Support Level 19.80
3rd Support Level 19.06

See More

52-Week High 25.74
Last Price 21.21
Fibonacci 61.8% 18.07
Fibonacci 50% 15.69
Fibonacci 38.2% 13.32
52-Week Low 5.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar